Form D · Biotechnology
Brain Neurotherapy Bio, Inc.
Research Triangle Park, NC · CIK 0001755511
Offering snapshot reported Oct 11, 2018 · SEC filing
- Reported sold
- $600 Offering amount: $600
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $4 Reported outside-investor minimum
- First sale
- Oct 1, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 11, 2018 | Initial | $600 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-323329
Source: Form D, filed Oct 11, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Krystof Bankiewicz | Director, Executive |
| Sheila Mikhail | Director, Executive |
| Jude Samulski | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
20 Tw Alexander Drive Suite 110
Research Triangle Park, NC, 27709
Research Triangle Park, NC, 27709